Nanomol
    Technologies

  • The company
  • Successful cases
  • R+D
  • Clients
  • News
  • Contact

    Particle
    technologies
  • Delos enabled products
  • Benefits and advantages
  • Partnering
  • Delos nanovesicles
  • Solid particulate materials

    Contract
    analysis
  • Services
  • Analysis
  • Quality
  • Expertise and equipment

News

2021
Nanomol Technologies will participate in the 11th annual PODD

Nanomol Technologies will participate in the 11th annual PODD

22 October 2021
NANOMOL TECHNOLOGIES HAS VISITED COSMETORIUM 2021, THE FIFTH EDITION OF THE EVENT ORGANIZED BY SOCIEDAD ESPAÑOLA DE QUÍMICOS COSMÉTICOS (SEQC)

NANOMOL TECHNOLOGIES HAS VISITED COSMETORIUM 2021, THE FIFTH EDITION OF THE EVENT ORGANIZED BY SOCIEDAD...

21 October 2021
NANOMOL TECHNOLOGIES PARTICIPATES AT NANODAY 2021

NANOMOL TECHNOLOGIES PARTICIPATES AT NANODAY 2021

13 October 2021
WORKSHOP IN HONOUR OF OUR COFOUNDERS PROFS JAUME VECIANA & CONCEPCIÓ ROVIRA

WORKSHOP IN HONOUR OF OUR COFOUNDERS PROFS JAUME VECIANA & CONCEPCIÓ ROVIRA

01 October 2021
NANOMOL TECHNOLOGIES IS PRESENT AT EXPOQUIMIA 2021

NANOMOL TECHNOLOGIES IS PRESENT AT EXPOQUIMIA 2021

08 September 2021
SANTI SALA, CEO AND COFOUNDER OF NANOMOL TECHNOLOGIES, WILL PARTICIPATE ON JUNE 29 IN A TECH TRANSFER FORUM

SANTI SALA, CEO AND COFOUNDER OF NANOMOL TECHNOLOGIES, WILL PARTICIPATE ON JUNE 29 IN A...

23 June 2021
Our paper has been selected for the cover image of the June 2021 issue of Advanced Therapeutics!

Our paper has been selected for the cover image of the June 2021 issue of...

21 June 2021
NEW DELOS NANOMEDICINE FOR THE TOPICAL TREATMENT OF COMPLEX WOUNDS

NEW DELOS NANOMEDICINE FOR THE TOPICAL TREATMENT OF COMPLEX WOUNDS

13 April 2021
NANOMOL TECHNOLOGIES IS OFFICIAL PARTNER OF 12TH GLOBAL DDF SUMMIT DRUG DELIVERY & FORMULATION

NANOMOL TECHNOLOGIES IS OFFICIAL PARTNER OF 12TH GLOBAL DDF SUMMIT DRUG DELIVERY & FORMULATION

16 March 2021
DELOS based nanoformulation for Fabry Disease designed as Orphan Drug

DELOS based nanoformulation for Fabry Disease designed as Orphan Drug

28 February 2021
Nanomol Technologies receives Crédit d’Impôt Recherche (CIR) accreditation by the French Ministry of Higher Education and Research

Nanomol Technologies receives Crédit d’Impôt Recherche (CIR) accreditation by the French Ministry of Higher Education...

08 February 2021
Nanomol Technologies will participate on February 3 in the final workshop of the H2020 European project Smart4Fabry

Nanomol Technologies will participate on February 3 in the final workshop of the H2020 European...

01 February 2021
  • First
  • 01
  • 02
  • 03
    • Last

come and visit us

NANOMOL TECHNOLOGIES, S.L.
Mòdul de Recerca B
UAB CAMPUS

08193 Bellaterra
Cerdanyola del Vallès
Barcelona
Spain

get in touch

T +34 935 868 963
INFO@NANOMOL-TECH.COM

follow us

Twitter Linkedin

terms of use

Privacy policy Legality

Copyright © 2021

Nanomol Technologies S.L.

Site by Suki

This website uses cookies.